Increased Plasma Thioredoxin in Patients with Acute Myocardial Infarction

Clinical Cardiology

Volumn 26, Issue 12, 2003, Pages 583-587

  Soejima, Hirofumi ^a   Suefuji, Hisakazu ^a   Miyamoto, Shinzo ^a   Kajiwaram, Ichiro ^a   Kojima, Sunao ^a   Hokamaki, Jun ^a   Sakamoto, Tomohiro ^a   Yoshimura, Michihiro ^a   Nakamura, Hajime ^b   Yodoi, Junji ^b   Ogawa, Hisao ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Oxidative stress; Reperfusion; Thioredoxin

Indexed keywords

BIOLOGICAL MARKER; THIOREDOXIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY REPERFUSION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PREDICTION; STABLE ANGINA PECTORIS; THORAX PAIN;

EID: 10744231453     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960261208     Document Type: Article

References (23)

1. Kostner K, Hornykewycz S, Yang P, Neunteufl T, Glogar D, Weidinger F, Maurer G, Huber K: Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc Res 1997;36:330-336
2. Cipollone F, Ciabattoni G, Patrignani P, Pasquale M, Di Gregorio D, Bucciarelli T, Davi G, Cuccurullo F, Patrono C: Oxidative stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 2000;102:1007-1013
3. Nakamura H, DeRosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA, Herzenberg LA: Elevation of plasma thioredoxin levels in HIV infected individuals. Int Immunol 1996;8:603-611
4. Nakamura H, Vaage J, Valen G, Padilla A, Björnstedt M, Holmgren A: Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radical Biol Med 1998;24:1176-1186
5. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, Kugiyama K, Obata K, Morikami Y, Kimura T: Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-963
6. Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, Sasayama S: Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J 2001;65:491-494
7. Nakamura H, Nakamura K, Yodoi J: Redox regulation of cellular activation. Ann Rev Immunol 1997;15:351-369
8. Takagi Y, Gon Y, Todaka T, Nozaki K, Nishiyama A, Sono H, Hashimoto N, Kikuchi H, Yodoi J: Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteries. Lab Invest 1998;78:957-966
9. Kaikita K, Ogawa H, Yasue H, Takeya M, Takahashi K, Saito T, Hayasaki K, Horiuchi K, Takizawa A, Kamikubo Y, Nakamura S: Tissue factor expression on macrophages in coronary plaques in patients with unstable angina. Arterioscler Thromb Vasc Biol 1997;17:2232-2237
10. Akiyama K, Kimura A, Suzuki H, Takeyama Y, Gluckman TL, Terhakopian A, Katagiri T, Suh KY, Roseto J, Bing RJ: Production of oxidative products of nitric oxide in infarcted human heart. J Am Coll Cardiol 1998;32:373-379
11. Riemersma RA, Wood DA, Macintyre CCCA, Elton RA, Gey KF, Oliver MF: Risk of angina pectoris and plasma concentmtions of vitamin A, C, and E as well as carotene. Lancet 1991;337:1-5
12. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H: Vitamin E deficiency in variant angina. Circulation 1996;94:14-18
13. Durrington PN, Mackness B, Mackness MI: Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473-480
14. Vaddi K, Nicolini FA, Mehta P, Mehta JL: Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation 1994;90:694-699
15. Ruef J, Peter K, Nordt TK, Runge MS, Kubler W, Bode C: Oxidative stress and atherosclerosis: Its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb Haemost 1999;82:32-37
16. Ramires PR, Ji LL: Glutathione supplementation and training increases myocardial resistance to ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 2001;281:H679-688
17. Gryglewski RJ, Palmer RMJ, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456
18. White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM: Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 1994;91:1044-1048
19. Diaz MN, Frei B, Vita JA, Keaney JF: Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-416
20. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107-1113
21. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H, Yasue H: Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998;32: 1672-1679
22. Tsunekawa T, Hayashi T, Kano H, Sumi D, Matsui-Hirai H, Thakur NK, Egashira K, Iguchi A: Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 2001;104:376-379
23. On YK, Kim CH, Oh BH, Lee MM, Park YB: Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. Hypertens Res 2002;25:365-371